Project Grant R43AG084460
Award Date
9/1/23
Completion Date
8/31/24
Dollars Obligated
$645K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Houston, TX 77005, USA
Similar Awards
This $485,375 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support the development and evaluation of a 3D engineered muscle tissue model to study the metabolic response to muscle contraction in the context of aging. The University of Washington, a prominent research institution, will lead this 2-year project to: 1) examine the mitochondrial mechanisms underlying the decreased metabolic response to muscle contraction in aged human 3D engineered...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $1,127,548 to the University of Texas Medical Branch at Galveston to investigate the role of post-translational modifications of myosin and its chaperone UNC-45 in the development of sarcopenia, the age-related loss of muscle mass and function. The project aims to use a combination of in vitro biochemical and biophysical assays, as well as in vivo techniques in the C. elegans model organism,...
This $485,375 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund research at the University of Washington to investigate genomic alterations in skeletal muscle associated with aging. The key objectives are to: Explore if alternative splicing of mRNA results in quantitative differential isoform changes associated with aging, potentially leading to increased expression of non-functional proteins relevant for healthy muscle function. The researchers...
This Project Grant award of $387,006 from the National Institute on Aging (NIA) under CFDA Program 93.866 - Aging Research supports research to understand how indoles derived from commensal gut bacteria can promote mobility and counteract sarcopenia (age-related muscle wasting) in aging animals. The research aims to determine the mechanisms by which indoles regulate muscle protein homeostasis, mitochondrial function, and other cellular pathways to maintain muscle mass and function during...
This $659,916 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to test the ability of diets with reduced levels of specific amino acids (isoleucine, valine, or histidine) to reverse diet-induced obesity and insulin resistance. The primary objectives are to determine the optimal degree of amino acid restriction to promote metabolic health in animal models, and to evaluate the efficacy of an optimized amino acid-restricted diet in...
This Project Grant from the National Institutes of Health's National Institute on Aging, under the Aging Research program (CFDA 93.866), provides $287,218.16 in funding to the University of Maryland, Baltimore from August 1, 2021 through March 27, 2022. The award supports research aimed at better understanding the impact of aging on muscle excitability and action potential conduction velocity. Specifically, the recipient will use electrophysiology techniques and optical imaging to examine...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Washington provides $485,375 to investigate the mechanisms underlying reduced resilience and adaptability of aging skeletal muscle. The project aims to determine whether increased mitochondrial redox stress drives the impairment of redox stress response signaling and declining muscle function with age. The researchers will use skeletal muscle contraction as a model to examine the...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $3,343,725 to The Spaulding Rehabilitation Hospital Corporation to investigate the effects of muscle aging and activity on extracellular vesicle regulation of muscle regeneration. The primary goals are to: 1) examine how aging of the skeletal muscle extracellular matrix alters the molecular composition of muscle-derived extracellular vesicles and impacts muscle stem cell myogenicity and...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research Federal Grant Program (CFDA 93.866), is focused on developing a RUNX1 modulator to slow cognitive decline in Alzheimer's disease (AD). The $391,850 award, with a period of performance from June 15, 2025 to August 31, 2026, is funding Third Element Bio Inc. to: 1) conduct lead optimization of RUNX1-targeting antisense oligonucleotides (ASOs) to improve their safety and potency, and 2) demonstrate the...
This federal Project Grant award of $507,325 from the National Institute on Aging (CFDA 93.866 - Aging Research) to the University of Texas Health Science Center at Houston (UTHealth) aims to investigate the role of ROR (retinoid acid receptor-related orphan receptor) nuclear receptors in regulating mitochondrial function and skeletal muscle aging. The key objectives are to: 1) comprehensively examine age- and circadian time-dependent changes in mitochondrial activity and homeostasis in skeletal...